RICHTER'S SYNDROME
Clinical trials for RICHTER'S SYNDROME explained in plain language.
Never miss a new study
Get alerted when new RICHTER'S SYNDROME trials appear
Sign up with your email to follow new studies for RICHTER'S SYNDROME, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New antibody combo shows promise for tough blood cancers
Disease control OngoingThis study tests an experimental drug called epcoritamab, given alone or with other medicines, in about 195 people whose chronic lymphocytic leukemia (CLL) or Richter's syndrome has stopped responding to standard treatments. The goal is to see if the drug is safe and can shrink o…
Matched conditions: RICHTER'S SYNDROME
Phase: PHASE1, PHASE2 • Sponsor: Genmab • Aim: Disease control
Last updated May 17, 2026 02:03 UTC
-
New pill shows promise for controlling blood cancer
Disease control OngoingThis study tests a new drug called acalabrutinib for people with chronic lymphocytic leukemia (CLL) or related blood cancers. The goal is to see if the drug is safe and can shrink or control the cancer. Participants take the drug by mouth, and the study tracks side effects and ho…
Matched conditions: RICHTER'S SYNDROME
Phase: PHASE1, PHASE2 • Sponsor: Acerta Pharma BV • Aim: Disease control
Last updated May 11, 2026 20:38 UTC